4//SEC Filing
VENROCK ASSOCIATES IV L P 4
Accession 0001209191-18-050122
CIK 0001600132other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 5:45 PM ET
Size
23.0 KB
Accession
0001209191-18-050122
Insider Transaction Report
Form 4
VENROCK ASSOCIATES IV L P
10% Owner
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds)
Venrock Management IV, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds)
Venrock Partners Management, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds)
Venrock Partners, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds)
VENROCK ENTREPRENEURS FUND IV L P
10% Owner
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds)
VEF Management IV, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds)
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds)
Koh Bong Y
10% Owner
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds)
VHCP Co-Investment Holdings II, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds)
VHCP Management II, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-09-05$0.85/sh+50,000$42,325→ 6,591,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-06$0.84/sh+50,000$42,095→ 6,641,163 total(indirect: By funds) - Purchase
Common Stock
2018-09-07$0.90/sh+60,000$53,742→ 6,701,163 total(indirect: By funds)
Footnotes (3)
- [F1]This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons.
- [F2]Consists of (i) 45,455 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 4,545 shares purchased by VHCP Co-Investment Holdings III, LLC.
- [F3]Consists of (i) 54,546 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 5,454 shares purchased by VHCP Co-Investment Holdings III, LLC.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001277997
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 5:45 PM ET
- Size
- 23.0 KB